Stock market week-in-review for 5 large GI companies — Nov. 13-17

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Nov. 13 to Nov. 17.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $172.21 on Nov. 13
Peaked: $176.14 on Nov. 17
Closed: $174.92 on Nov. 17
Percent change between Nov. 13 and Nov. 17: 1.57 percent

2. Exact Sciences Corp.

Opened: $60.37 on Nov. 13
Peaked at open
Closed: $58.86 on Nov. 17
Percent change between Nov. 13 and Nov. 17: -2.50 percent

3. Johnson & Johnson

Opened: $138.80 on Nov. 13
Peaked: $140.26 on Nov. 14
Closed: $137.98 on Nov. 17
Percent change between Nov. 13 and Nov. 17: -0.59 percent

4. Synergy Pharmaceuticals

Opened: $2.72 on Nov. 13
Peaked at open
Closed: $1.95 on Nov. 17
Percent change between Nov. 13 and Nov. 17: -28.30 percent

5. Valeant Pharmaceuticals

Opened: $15.41 on Nov. 13
Peaked at open
Closed: $14.69 on Nov. 17
Percent change between Nov. 13 and Nov. 17: -4.67 percent

More articles on gastroenterology:
Physician fee schedule slashes GI anesthesia reimbursement — 5 insights
GI leader to know: Dr. John Vainder of Illinois Gastroenterology Group
Endoscopy a viable alternative to surgery for Barrett’s esophagus patients — 3 insights

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.